Verona Pharma plc buy Wells Fargo & Company
Start price
30.04.25
/
50%
€0.51
Target price
30.04.26
€94.11
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 30.04.26. The prediction end date can be changed by Wells_Fargo___Compan at any time.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Verona Pharma plc | - | - |
| iShares Core DAX® | 3,59 % | 3,93 % |
| iShares Nasdaq 100 | 5,81 % | 5,52 % |
| iShares Nikkei 225® | 4,08 % | 8,46 % |
| iShares S&P 500 | 4,14 % | 4,04 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Verona Pharma plc diskutieren
Verona Pharma plc (NASDAQ: VRNA) had its price target raised by analysts at Wells Fargo & Company from $93.00 to $107.00. They now have an "overweight" rating on the stock.
Ratings data for VRNA provided by MarketBeat